XBIO · Xenetic Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| James F. Parslow Interim CEO and CFO | ▲ Buy | Grant | 100,000 Shares held | 4/21/2026 | View profile |
Transaction History
| James F. Parslow | ▲ Buy | Grant | 100,000 | $0 | 4/21/2026 |
| James F. Parslow Interim CEO and CFO | ▲ Buy | Grant | 100,000 Shares held | 4/21/2026 | View profile |
| James F. Parslow | ▲ Buy | Grant | 100,000 | $0 | 4/21/2026 |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Xenetic Biosciences (XBIO) Moves in Monday Pre-Market
Xenetic Biosciences (XBIO) was one of 12 health‑care stocks that moved in the Monday pre‑market session. The early trading activity suggests increased investor interest ahead of the regular market open. XBIO’s price action in pre‑market was part of a broader shift among health‑care names that day.
Xenetic Biosciences (XBIO) Moves in Monday Pre-Market. Xenetic Biosciences (XBIO) was one of 12 health‑care stocks that moved in the Monday pre‑market session. The early trading activity suggests increased investor interest ahead of the regular market open. XBIO’s price action in pre‑market was part of a broader shift among health‑care names that day.